UTHR daily bearish hammer in selling resistance zoneOrder SELL UTHR NASDAQ.NMS Stop 209.45 LMT 209.45 will be automatically canceled at 20230401 01:00:00 EST
UTHR daily bearish hammer in selling resistance zone
21.05USD
984.80 MUSD
2.33 BUSD
43.37 M
About United Therapeutics Corporation
Sector
CEO
Martine A. Rothblatt
Headquarters
Silver Spring
Website
Employees (FY)
1.17 K
Founded
1996
ISIN
US91307C1027
FIGI
BBG000BV4XJ1
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
UTHR daily indecision candle at resistanceOrder SELL UTHR NASDAQ.NMS Stop 211.77 LMT 211.77 will be automatically canceled at 20230401 01:00:00 EST
UTHR daily indecision hammer at resistance can be nice ride into support zone.
Descending TriangleCould break either way. Any triangle can break up or down. It is a consolidation pattern
Also a H&S pattern.
The talking heads are saying Buy healthcare so be safe, or not. The players will run HC up until it will cave as well.
They usually do the same thing over and over and suck us in a long
UTHR - No ResistanceUTHR has no resistance (shown with dotted green horizontal)
A breakout should ensue and lead to further bullish increases
This is all occurring along a strong up trend line formed by the bulls
UTHR - A Reminder to let trades breathe!!!I went long UTHR on Tuesday, as per the position marked.
Its consolidating nicely after breaking out from a previous high and looked really good.
Unfortunately I messed the whole thing up!!!
I got a pretty nasty entry (got a little too trigger happy on the breakout).
My strategy as always but es
UTHR H&S top with Bear pennantFollowing up on August 22nd idea. Will today be the day UTHR tests its neckline?
Head & Shoulders Top Formation $UTHR$UTHR has built a text book classic Head & Shoulders top. It is resting near its neckline breakdown area $213.75. Consolidation above the neckline breakdown area of $215-$220 has created a bearish looking pennant formation. All in all $UTHR looks sickly, and probably headed for lower prices. If ne
Head and ShouldersPrice is on the neckline.
Earnings miss.
Entry short with a break of the neckline and a downtrend.
No recommendation.
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chroni
$UTHR #supertrend #breakout$UTHR Breakout in 1h Chart
Target 262$
Stop-Loss 236$
Risk Reward Ratio 2.7
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where UTHR is featured.
Frequently Asked Questions
The current price of UTHR is 237.93 USD — it has increased by 0.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange United Therapeutics Corporation stocks are traded under the ticker UTHR.
United Therapeutics Corporation is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
UTHR stock is 1.48% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is United Therapeutics Corporation there?
One year price forecast for United Therapeutics Corporation has a max estimate of 375.00 USD and a min estimate of 183.00 USD.
UTHR earnings for the last quarter are 5.38 USD per share, whereas the estimation was 5.10 USD resulting in a 5.45% surprise. The estimated earnings for the next quarter are 4.28 USD per share. See more details about United Therapeutics Corporation earnings.
United Therapeutics Corporation revenue for the last quarter amounts to 609.40 M USD despite the estimated figure of 585.82 M USD. In the next quarter revenue is expected to reach 575.01 M USD.
Yes, you can track United Therapeutics Corporation financials in yearly and quarterly reports right on TradingView.
UTHR stock has fallen by 0.02% compared to the previous week, the month change is a 0.15% fall, over the last year United Therapeutics Corporation has showed a 5.67% increase.
UTHR net income for the last quarter is 217.10 M USD, while the quarter before that showed 267.60 M USD of net income which accounts for −18.87% change. Track more United Therapeutics Corporation financial stats to get the full picture.
Today United Therapeutics Corporation has the market capitalization of 11.15 B, it has increased by 3.67% over the last week.
No, UTHR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, UTHR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade United Therapeutics Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.17 K employees. See our rating of the largest employees — is United Therapeutics Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So United Therapeutics Corporation technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating United Therapeutics Corporation stock shows the buy signal. See more of United Therapeutics Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on United Therapeutics Corporation future price: according to them, UTHR price has a max estimate of 375.00 USD and a min estimate of 183.00 USD. Read a more detailed United Therapeutics Corporation forecast: see what analysts think of United Therapeutics Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. United Therapeutics Corporation EBITDA is 1.24 B USD, and current EBITDA margin is 53.35%. See more stats in United Therapeutics Corporation financial statements.